Teachers Advisors LLC acquired a new position in shares of Cardlytics Inc (NASDAQ:CDLX) in the third quarter, Holdings Channel reports. The fund acquired 10,519 shares of the company’s stock, valued at approximately $263,000.
Several other institutional investors also recently made changes to their positions in the stock. Kornitzer Capital Management Inc. KS grew its position in Cardlytics by 25.3% during the third quarter. Kornitzer Capital Management Inc. KS now owns 97,700 shares of the company’s stock worth $2,446,000 after buying an additional 19,700 shares in the last quarter. Allianz Asset Management GmbH acquired a new stake in Cardlytics during the third quarter worth approximately $4,282,000. North Fourth Asset Management LP acquired a new stake in Cardlytics during the third quarter worth approximately $2,614,000. Regents of The University of California acquired a new stake in Cardlytics during the third quarter worth approximately $1,348,000. Finally, Monashee Investment Management LLC acquired a new stake in Cardlytics during the third quarter worth approximately $1,540,000. 74.12% of the stock is owned by institutional investors and hedge funds.
NASDAQ CDLX opened at $16.56 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 3.04 and a current ratio of 3.04. Cardlytics Inc has a fifty-two week low of $9.80 and a fifty-two week high of $28.29.
Cardlytics (NASDAQ:CDLX) last released its earnings results on Tuesday, November 13th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.63) by $0.48. The business had revenue of $34.58 million for the quarter, compared to the consensus estimate of $37.62 million. The business’s revenue was up 10.1% compared to the same quarter last year. Sell-side analysts forecast that Cardlytics Inc will post -1.98 EPS for the current year.
In other Cardlytics news, CFO David Thomas Evans sold 27,147 shares of the company’s stock in a transaction on Tuesday, December 11th. The stock was sold at an average price of $13.50, for a total transaction of $366,484.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Scott D. Grimes sold 27,353 shares of the company’s stock in a transaction on Wednesday, December 12th. The stock was sold at an average price of $13.49, for a total value of $368,991.97. The disclosure for this sale can be found here. Insiders have sold 108,503 shares of company stock valued at $1,464,517 over the last 90 days.
A number of equities research analysts recently issued reports on CDLX shares. Bank of America raised Cardlytics from a “neutral” rating to a “buy” rating and set a $15.00 price target on the stock in a research report on Tuesday, January 15th. Zacks Investment Research downgraded Cardlytics from a “hold” rating to a “sell” rating in a research report on Tuesday, October 9th. JPMorgan Chase & Co. reduced their price target on Cardlytics from $31.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 14th. Morgan Stanley reduced their price target on Cardlytics from $28.00 to $26.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 14th. Finally, Raymond James reduced their price target on Cardlytics from $23.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 14th. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $22.38.
ILLEGAL ACTIVITY NOTICE: This story was reported by Enterprise Leader and is the property of of Enterprise Leader. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://theenterpriseleader.com/2019/02/06/teachers-advisors-llc-acquires-shares-of-10519-cardlytics-inc-cdlx.html.
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Recommended Story: What impact do institutional investors have on markets?
Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics Inc (NASDAQ:CDLX).
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.